Riskpilot← Back to searchSign inGet full accessDiagnosen Oskarshamn AB
ABIn liquidationOrg 5592954076Rental and operating of own or leased real estate · NACE 6820Est. 20210 employees
Revenue 2023
SEK 643K
-50% vs 2022
EBITDA margin
59.7%
-96% vs 2022
Equity ratio
63.0%
Financial strength
Net profit 2023
SEK 36K
-99% vs 2022
| Revenue | SEK 643K | -50% |
| EBITDA | SEK 384K | -96% |
| Net profit | SEK 36K | -99% |
| Total assets | SEK 6,7M | -68% |
| Equity | SEK 4,2M | +1% |
| Employees | 0 | — |
Legal name
Diagnosen Oskarshamn AB
Org number
5592954076
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
8 januari 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 2 605 | 1 288 | 643 |
| Staff expenses | — | — | — |
| EBITDA | 1 432 | 9 898 | 384 |
| Depreciation & amort. | −339 | — | — |
| EBIT | 1 093 | 9 898 | 384 |
| Net financials | −206 | −311 | −276 |
| Profit before tax | 665 | 4 564 | 52 |
| Tax | −137 | −941 | −17 |
| Net profit | 528 | 3 623 | 36 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 13 668 | 20 968 | 6 681 |
| Equity | 553 | 4 177 | 4 212 |
| Long-term debt | 11 236 | 0 | — |
| Short-term debt | 1 657 | 15 048 | 2 469 |
| Total debt | 12 893 | 15 048 | 2 469 |
EBITDA margin
59.7%
This company
15.8%
Market median
+278% vs market
20212023
Equity ratio
63.0%
This company
38.2%
Market median
+65% vs market
20212023
Return on equity
0.8%
This company
18.4%
Market median
-96% vs market
20212023
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20212023
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20212023
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20212023
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (9) | ||
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2024 | |
| Deputy Board Member | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
P&S HOLDINGS
Diagnosen Oskarshamn AB Board members of Diagnosen Oskarshamn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Martin Rosengren | Liquidator | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Pär Kennert Eriksson | Board of Directors | 0 companies |
| Emanuel Erik Hesselbäck | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Per Erik Daniel Ahlqvist | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Nimrod Sofer | Board of Directors | 0 companies |
| Nimrod Sofer | Board of Directors | 0 companies |